Table 2.

Numbers of participants with additional features, by age group and sex, and by feature–cancer combination

Cancer and additional featureWomen, n (%)Men, n (%)
Aged 40–59 years (n= 29 920)Aged 60–69 years (n = 14 955)Aged ≥70 years (n= 23 008)Aged 40–59 years (n= 29 944)Aged 60–69 years (n = 14 506)Aged ≥70 years (n= 13 460)
Colorectal, ovary, oesophagogastric, liver
Abdominal mass67 (0.2)51 (0.3)85 (0.4)63 (0.2)32 (0.2)57 (0.4)
Colorectal, ovary
Change in bowel habit281 (0.9)201 (1.3)330 (1.4)n/an/an/a
Colorectal, pancreas
Constipation810 (2.7)586 (3.9)1765 (7.7)645 (2.2)574 (4.0)1118 (8.3)
Diarrhoea988 (3.3)648 (4.3)1474 (6.4)1065 (3.6)578 (4.0)644 (4.8)
Pancreas, oesophagogastric
Nausea and/or vomiting833 (2.8)567 (3.8)1486 (6.5)626 (2.1)325 (2.2)587 (4.4)
Colorectal, oesophagogastric, pancreas, ovary
Weight loss108 (0.4)91 (0.6)316 (1.4)158 (0.5)116 (0.8)222 (1.6)
Bladder, kidney
Haematuria100 (0.3)88 (0.6)129 (0.6)182 (0.6)119 (0.8)199 (1.5)
Urinary tract infection1514 (5.1)1013 (6.8)2183 (9.5)352 (1.2)261 (1.8)506 (3.8)
Uterus, oesophagogastric
Low haemoglobin2145 (7.2)1209 (8.1)4069 (17.7)n/an/an/a
Raised platelets1001 (3.3)636 (4.3)1348 (5.9)n/an/an/a
  • n/a = not applicable: included because people born of male sex cannot be diagnosed with uterine cancer or with ovarian cancer.